| NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody M Malviya, S Barman, KS Golombeck, J Planagumà, F Mannara, ... Annals of clinical and translational neurology 4 (11), 768-783, 2017 | 119 | 2017 |
| N‐methyl‐D‐aspartate receptor antibodies in autoimmune encephalopathy alter oligodendrocyte function C Matute, A Palma, MP Serrano‐Regal, E Maudes, S Barman, ... Annals of neurology 87 (5), 670-676, 2020 | 36 | 2020 |
| Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity T Ruck, S Barman, A Schulte-Mecklenbeck, S Pfeuffer, F Steffen, C Nelke, ... Brain 145 (5), 1711-1725, 2022 | 31 | 2022 |
| Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis SK Wright, RE Rosch, MA Wilson, MA Upadhya, DR Dhangar, ... Communications biology 4 (1), 1106, 2021 | 26 | 2021 |
| Dose‐dependent inhibition of demyelination and microglia activation by IVIG M Winter, C Baksmeier, J Steckel, S Barman, M Malviya, M Harrer‐Kuster, ... Annals of clinical and translational neurology 3 (11), 828-843, 2016 | 23 | 2016 |
| Genetic diversity analysis of chewing sugarcane (Saccharum officinarum L.) varieties by using RAPD markers. SM Sarid Ullah, MA Hossain, MM Hossain, S Barman, MM Hasan Sohag, ... Journal of BioScience & Biotechnology 2 (2), 2013 | 15 | 2013 |
| An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis E Amedonu, C Brenker, S Barman, JA Schreiber, S Becker, S Peischard, ... Frontiers in Neurology 10, 178, 2019 | 4 | 2019 |
| In vitro characterisation and neurosteroid treatment of an N-Methyl-D-Aspartate receptor antibody-mediated seizure model SK Wright, RE Rosch, MA Wilson, MA Upadhya, DR Dhangar, ... bioRxiv, 2020.12. 22.423962, 2020 | 1 | 2020 |
| Characterization of T cells in NMOSD patients-an emerging role for T cells in disease pathogenesis (4017) M Lindner, U Bhatia, A Schulte-Mecklenbeck, T Wirth, C Gross, T Schmidt, ... Neurology 94 (15_supplement), 4017, 2020 | 1 | 2020 |
| Effect of Alemtuzumab (LEMTRADA®) treatment on the peripheral immune repertoire in multiple sclerosis patients NG S. Barman1, A. Scheffler1, T. Ruck2, C. Lehrich2, A. Coordt1, P ... MULTIPLE SCLEROSIS JOURNAL, 2019 | 1 | 2019 |
| The influence of T cells in NMO disease pathogenesis M Lindner, U Bhatia, A Schulte-Mecklenbeck, T Wirth, C Gross, M Korsen, ... MULTIPLE SCLEROSIS JOURNAL 24, 334-335, 2018 | 1 | 2018 |
| Identification of Autoantibody Producing Plasma Cells in the CSF of Autoimmune Encephalitis (AIE) Patients (P6. 132) N Goebels, M Malviya, S Barman, N Melzer, C Elger, H Wiendl, ... Neurology 86 (16_supplement), P6. 132, 2016 | 1 | 2016 |
| Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering C Nelke, CB Schroeter, S Barman, F Stascheit, L Masanneck, L Theissen, ... Ebiomedicine 105, 2024 | | 2024 |
| KSHV infection of B cells primes protective T cell responses in humanized mice N Caduff, L Rieble, M Böni, D McHugh, R Roshan, W Miley, N Labo, ... Nature Communications 15 (1), 4841, 2024 | | 2024 |
| Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls S Räuber, C Nelke, CB Schroeter, S Barman, M Pawlitzki, J Ingwersen, ... Frontiers in Immunology 14, 1198860, 2023 | | 2023 |
| Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls K DiSano, JJ Garcia-Vallejo, S Räuber, S Räuber, C Nelke, CB Schroeter, ... | | 2023 |
| Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity MF Sabet, S Barman, M Beller, SG Meuth, N Melzer, O Aktas, N Goebels, ... International Journal of Molecular Sciences 24 (1), 248, 2022 | | 2022 |
| Distinct immune repertoire characteristics are associated with secondary autoimmunity following LEMTRADA® therapy (P13-4.009) S Barman, T Ruck, C Lehrich, HP Hartung, N Melzer, H Wiendl, S Meuth, ... Neurology 98 (18_supplement), 2702, 2022 | | 2022 |
| Effect of Alemtuzumab (LEMTRADA®) Treatment on the Peripheral Immune Repertoire in Multiple Sclerosis Patients (4148) S Barman, A Scheffler, T Ruck, C Lehrich, V Balz, H Wiendl, S Meuth, ... Neurology 94 (15_supplement), 4148, 2020 | | 2020 |
| The emerging role of T cells in NMOSD disease pathogenesis M Lindner, U Bhatia, A Schulte-Mecklenbeck, T Wirth, C Gross, T Schmidt, ... MULTIPLE SCLEROSIS JOURNAL 25, 589-590, 2019 | | 2019 |
